Resonance Health Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 3.27 million compared to AUD 2.1 million a year ago. Net loss was AUD 0.557552 million compared to AUD 0.251793 million a year ago.

Basic loss per share from continuing operations was AUD 0.0012 compared to AUD 0.0005 a year ago. Diluted loss per share from continuing operations was AUD 0.0012 compared to AUD 0.0005 a year ago.